Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 14 04:00PM ET
7.20
Dollar change
-0.58
Percentage change
-7.46
%
Index- P/E- EPS (ttm)-0.92 Insider Own13.83% Shs Outstand14.41M Perf Week0.14%
Market Cap105.26M Forward P/E- EPS next Y-1.50 Insider Trans0.05% Shs Float12.60M Perf Month-14.29%
Income-10.30M PEG- EPS next Q-0.17 Inst Own22.99% Short Float1.64% Perf Quarter-28.92%
Sales6.13M P/S17.17 EPS this Y-41.35% Inst Trans- Short Ratio2.67 Perf Half Y2.71%
Book/sh2.23 P/B3.23 EPS next Y-34.78% ROA-37.49% Short Interest0.21M Perf Year46.34%
Cash/sh2.46 P/C2.92 EPS next 5Y- ROE-42.32% 52W Range3.21 - 10.69 Perf YTD-2.83%
Dividend Est.- P/FCF- EPS past 5Y- ROI-31.66% 52W High-32.65% Beta0.77
Dividend TTM- Quick Ratio8.64 Sales past 5Y0.00% Gross Margin99.55% 52W Low124.30% ATR (14)0.67
Dividend Ex-Date- Current Ratio8.64 EPS Y/Y TTM- Oper. Margin-161.82% RSI (14)40.99 Volatility10.13% 8.83%
Employees8 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin-168.11% Recom1.00 Target Price15.67
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q-27.01% Payout- Rel Volume1.31 Prev Close7.78
Sales Surprise- EPS Surprise-16.67% Sales Q/Q- EarningsMay 09 AMC Avg Volume77.52K Price7.20
SMA20-7.68% SMA50-12.87% SMA2005.34% Trades Volume101,246 Change-7.46%
Jun-11-24 08:15AM
Jun-03-24 08:15AM
May-28-24 08:15AM
May-27-24 12:32PM
11:43AM
08:52AM Loading…
May-23-24 08:52AM
May-22-24 08:15AM
May-20-24 09:10AM
08:15AM
May-10-24 03:54PM
May-09-24 04:10PM
Apr-26-24 08:15AM
Apr-22-24 08:15AM
Apr-18-24 08:15AM
Apr-08-24 08:15AM
05:31AM Loading…
Mar-21-24 05:31AM
Mar-19-24 09:53PM
08:15AM
Mar-12-24 09:00AM
08:00AM
Mar-06-24 08:15AM
Feb-29-24 08:15AM
Feb-22-24 08:15AM
Feb-21-24 08:15AM
Feb-13-24 08:15AM
Jan-29-24 08:15AM
Jan-18-24 08:15AM
Jan-16-24 08:15AM
03:59AM
Jan-05-24 08:00AM
08:30AM Loading…
Dec-20-23 08:30AM
Dec-14-23 03:54PM
03:54PM
Dec-13-23 08:00AM
Dec-12-23 08:00AM
Dec-06-23 07:05AM
07:00AM
Nov-08-23 09:00AM
Oct-27-23 09:00AM
Oct-09-23 08:00AM
Oct-05-23 09:00AM
Oct-03-23 09:00AM
Sep-27-23 09:00AM
Sep-22-23 09:00AM
Sep-07-23 09:15AM
Aug-31-23 08:00AM
Aug-25-23 09:00AM
Aug-21-23 01:31PM
07:00AM
Aug-08-23 07:00AM
Aug-03-23 07:00AM
Jul-19-23 07:00AM
Jul-17-23 12:21PM
07:00AM
Jul-05-23 08:30AM
Jun-28-23 07:00AM
Jun-20-23 07:00AM
Jun-14-23 07:00AM
Jun-12-23 07:00AM
Jun-07-23 07:00AM
Jun-05-23 07:00AM
May-22-23 07:00AM
May-16-23 02:42PM
08:50AM
07:00AM
May-12-23 07:47AM
May-10-23 07:00AM
May-09-23 07:15AM
07:00AM
May-02-23 03:30PM
Apr-14-23 09:00AM
Mar-31-23 07:00AM
Mar-29-23 04:01PM
09:00AM
Mar-27-23 07:00AM
Mar-23-23 09:15AM
07:44AM
Mar-22-23 09:15AM
Mar-21-23 11:38AM
11:24AM
09:55AM
07:50AM
07:00AM
Mar-20-23 07:00AM
Mar-09-23 07:00AM
Mar-06-23 09:00AM
Feb-28-23 09:00AM
Feb-27-23 07:00AM
Feb-16-23 09:15AM
Feb-15-23 07:13AM
Feb-02-23 09:00AM
Jan-26-23 09:01AM
Jan-03-23 04:15PM
Dec-29-22 11:20AM
Coya Therapeutics, Inc. is a clinical-stage biotechnology company which engages in developing proprietary medicinal products to modulate the function of regulatory T cells. The company was founded by Howard Berman in 2020 and is headquartered in Houston, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lee AnnDirectorAug 22 '23Buy3.621,0003,62017,479Mar 05 08:00 PM